Angela Amar, dean of the UNLV School of Nursing, talks about two changes she has made during the coronavirus pandemic. (Las Vegas Review-Journal)
Search results for:
Dr. Michael Levin, investigator for the phase three trial of the first COVID-19 vaccine developed in the U.S. by the National Institute of Health and Moderna Inc., talks about what health experts hope to learn from the trial. (Rachel Aston/Las Vegas Review-Journal)
Peter Klamka, CEO of Cordia Corporation, had already been working on Cordia’s Virtual Dining Brands division when the pandemic hit. Now his idea may be the future of restaurants. (Rachel Aston/Las Vegas Review-Journal)